Nottingham City Hospital is a large hospital located in Nottingham, England. It occupies a large 90-acre site on the ring road to the North of the city centre. It is composed of many buildings, most of which are joined together by long corridors.

There are 1,100 beds in Nottingham University Hospitals NHS Trust.

During the past decade, Nottingham University Hospitals NHS Trust conducted 267 clinical trials. In the 10-year time frame, 267 clinical trials started and 62 clinical trials were completed, i.e. on average, 23.2% percent of trials that started reached the finish line to date. In the past 5 years, 104 clinical trials started and 40 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nottingham University Hospitals NHS Trust" #1 sponsor was "University of Nottingham" with 49 trials, followed by "Nottingham University Hospitals NHS Trust" with 37 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 26 trials sponsored, "Gilead Sciences" with 14 trials sponsored and "University College, London" with 14 trials sponsored. Other sponsors include 264 different institutions and companies that sponsored additional 174 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nottingham University Hospitals NHS Trust" #1 collaborator was "National Institute for Health Research, United Kingdom" with 19 trials as a collaborator, "Nottingham University Hospitals NHS Trust" with 14 trials as a collaborator, "Cancer Research UK" with 12 trials as a collaborator, "University of Nottingham" with 8 trials as a collaborator and "Medical Research Council" with 6 trials as a collaborator. Other collaborators include 427 different institutions and companies that were collaborators in the rest 313 trials.

According to Clinical.Site data, the most researched conditions in "Nottingham University Hospitals NHS Trust" are "Breast Cancer" (19 trials), "Cystic Fibrosis" (9 trials), "Lung Cancer" (9 trials), "Lymphoma" (9 trials) and "Multiple Myeloma" (8 trials). Many other conditions were trialed in "Nottingham University Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "Nottingham University Hospitals NHS Trust" are "Drug" (227 trials), "Other" (63 trials), "Procedure" (39 trials), "Biological" (34 trials) and "Device" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "radiation therapy" (14 trials), "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (11 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Nottingham University Hospitals NHS Trust" are 352 trials for "All" genders, 45 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 130 active trials in "Nottingham University Hospitals NHS Trust". 3 are not yet recruiting, 69 are recruiting, 55 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 184 completed trials in Nottingham University Hospitals NHS Trust, 5 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Nottingham University Hospitals NHS Trust, 20 "Phase 1" clinical trials were conducted, 99 "Phase 2" clinical trials and 138 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 71 trials that are defined as “Not Applicable".

Nottingham University Hospitals NHS Trust has several departments that took part in Clinical trials: "Nottingham City Hospital; Oncology" - 15 trials, "Nottingham City Hospital; Dept of Haematology" - 11 trials, "Nottingham Children's Hospital" - 10 trials, "Nottingham Renal and Transplant Unit, Nottingham City Hospital" - 4 trials, "Uni Hospital Queens Medical Centre; Neurology" - 2 trials, "Radiology Department" - 2 trials, "Nottingham University Hospitals City Campus; Nottingham Cancer Clinical Trials Team" - 2 trials, "Histopathology Department" - 2 trials